CORCEPT THERAPEUTICS INC Financing Cash Flow
CORCEPT THERAPEUTICS INC (CORT) reported Financing Cash Flow of -$1.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$2.04M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $760.00K.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$31.22M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$46.41M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) financing activities for fiscal 2025 was -$220.37M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) financing activities for fiscal 2024 was -$28.35M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) financing activities for fiscal 2023 was -$148.72M.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) financing activities for fiscal 2022 was -$17.28M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 158 month | Net Cash Provided by (Used in) Financing Activities 161 month | Net Cash Provided by (Used in) Financing Activities 164 month | Net Cash Provided by (Used in) Financing Activities 167 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$1.28M 10-Q · filed 2026-07-29 | -$32.49M derived: sum of 3 quarters · filed 2026-07-29 | -$78.91M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $760.00K 10-Q · filed 2026-04-30 | -$30.46M derived: sum of 2 quarters · filed 2026-04-30 | -$76.87M derived: sum of 3 quarters · filed 2026-04-30 | -$179.80M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | -$31.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$77.63M derived: sum of 2 quarters · filed 2026-02-24 | -$180.56M derived: sum of 3 quarters · filed 2026-07-29 | -$220.37M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | -$46.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$149.35M derived: sum of 2 quarters · filed 2026-07-29 | -$189.15M 10-Q · filed 2025-11-04 | -$193.71M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | -$102.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$142.74M 10-Q · filed 2026-07-29 | -$147.30M derived: sum of 3 quarters · filed 2026-07-29 | -$168.39M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | -$39.80M 10-Q · filed 2026-04-30 | -$44.37M derived: sum of 2 quarters · filed 2026-04-30 | -$65.46M derived: sum of 3 quarters · filed 2026-04-30 | -$67.61M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | -$4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$25.66M derived: sum of 2 quarters · filed 2026-02-24 | -$27.81M derived: sum of 3 quarters · filed 2026-02-24 | -$28.35M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$21.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$23.24M derived: sum of 2 quarters · filed 2025-11-04 | -$23.79M 10-Q · filed 2025-11-04 | -$23.02M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$2.69M 10-Q · filed 2025-07-31 | -$1.93M derived: sum of 3 quarters · filed 2026-02-24 | -$5.84M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$543.00K 10-Q · filed 2025-05-05 | $223.00K derived: sum of 2 quarters · filed 2026-02-24 | -$3.69M derived: sum of 3 quarters · filed 2026-02-24 | -$149.45M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$3.15M derived: sum of 2 quarters · filed 2026-02-24 | -$148.90M derived: sum of 3 quarters · filed 2026-02-24 | -$148.72M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | -$3.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$149.67M derived: sum of 2 quarters · filed 2024-10-30 | -$149.49M 10-Q · filed 2024-10-30 | -$149.55M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | -$145.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | -$145.57M 10-Q · filed 2024-07-29 | -$145.63M derived: sum of 3 quarters · filed 2025-02-26 | -$159.59M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $181.00K 10-Q · filed 2024-05-01 | $120.00K derived: sum of 2 quarters · filed 2025-02-26 | -$13.84M derived: sum of 3 quarters · filed 2025-02-26 | -$16.60M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$14.02M derived: sum of 2 quarters · filed 2025-02-26 | -$16.78M derived: sum of 3 quarters · filed 2025-02-26 | -$17.28M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | -$13.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$16.72M derived: sum of 2 quarters · filed 2023-11-01 | -$17.22M 10-Q · filed 2023-11-01 | -$224.19M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$3.26M 10-Q · filed 2023-08-02 | -$210.23M derived: sum of 3 quarters · filed 2024-02-15 | -$233.87M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | -$506.00K 10-Q · filed 2023-05-03 | -$207.47M derived: sum of 2 quarters · filed 2024-02-15 | -$231.12M derived: sum of 3 quarters · filed 2024-02-15 | -$257.15M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | -$206.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$230.61M derived: sum of 2 quarters · filed 2024-02-15 | -$256.64M derived: sum of 3 quarters · filed 2024-02-15 | -$302.59M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | -$23.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$49.67M derived: sum of 2 quarters · filed 2022-11-03 | -$95.62M 10-Q · filed 2022-11-03 | -$96.28M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$26.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$71.98M 10-Q · filed 2022-08-04 | -$72.64M derived: sum of 3 quarters · filed 2023-02-28 | -$66.77M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$45.95M 10-Q · filed 2022-05-05 | -$46.61M derived: sum of 2 quarters · filed 2023-02-28 | -$40.74M derived: sum of 3 quarters · filed 2023-02-28 | -$33.94M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$661.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $5.21M derived: sum of 2 quarters · filed 2023-02-28 | $12.01M derived: sum of 3 quarters · filed 2023-02-28 | $12.21M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $5.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $12.67M derived: sum of 2 quarters · filed 2021-11-03 | $12.88M 10-Q · filed 2021-11-03 | $12.73M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2020-06-30 | $6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $7.01M 10-Q · filed 2021-07-29 | $6.87M derived: sum of 3 quarters · filed 2022-02-15 | $9.56M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2020-03-31 | $205.00K 10-Q · filed 2021-05-06 | $61.00K derived: sum of 2 quarters · filed 2022-02-15 | $2.76M derived: sum of 3 quarters · filed 2022-02-15 | -$13.15M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2019-12-31 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $2.55M derived: sum of 2 quarters · filed 2022-02-15 | -$13.36M derived: sum of 3 quarters · filed 2022-02-15 | -$28.64M 10-K · filed 2022-02-15 | ||||
| 2019-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$13.21M derived: sum of 2 quarters · filed 2020-11-03 | -$28.50M 10-Q · filed 2020-11-03 | -$40.53M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | -$15.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$31.20M 10-Q · filed 2020-08-04 | -$43.23M derived: sum of 3 quarters · filed 2021-02-23 | -$51.50M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | -$15.29M 10-Q · filed 2020-05-04 | -$27.32M derived: sum of 2 quarters · filed 2021-02-23 | -$35.59M derived: sum of 3 quarters · filed 2021-02-23 | -$31.55M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | -$12.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$20.30M derived: sum of 2 quarters · filed 2021-02-23 | -$16.26M derived: sum of 3 quarters · filed 2021-02-23 | -$14.34M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | -$8.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$4.23M derived: sum of 2 quarters · filed 2019-11-07 | -$2.30M 10-Q · filed 2019-11-07 | $263.00K derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $5.97M 10-Q · filed 2019-08-01 | $8.53M derived: sum of 3 quarters · filed 2020-02-24 | $6.69M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $1.92M 10-Q · filed 2019-05-09 | $4.49M derived: sum of 2 quarters · filed 2020-02-24 | $2.65M derived: sum of 3 quarters · filed 2020-02-24 | |||||
| 2017-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $726.00K derived: sum of 2 quarters · filed 2020-02-24 | -$7.95M 10-K · filed 2020-02-24 | |||||
| 2017-09-30 | -$1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | -$10.52M 10-Q · filed 2018-11-02 | ||||||
| 2017-06-30 | -$8.68M 10-Q · filed 2018-08-09 | |||||||
| 2016-12-31 | -$7.10M 10-K · filed 2019-02-26 | |||||||
| 2013-12-31 | -$592.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$970.00K 10-K · filed 2014-03-14 | ||||||
| 2013-09-30 | -$378.00K 10-Q · filed 2013-11-12 | |||||||
| 2012-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $76.21M derived: sum of 2 quarters · filed 2014-03-14 | $76.41M derived: sum of 3 quarters · filed 2014-03-14 | $89.57M 10-K · filed 2014-03-14 | ||||
| 2012-09-30 | $76.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $76.21M derived: sum of 2 quarters · filed 2013-11-12 | $89.36M 10-Q · filed 2013-11-12 | $89.41M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $198.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $13.35M 10-Q · filed 2013-08-09 | $13.40M derived: sum of 3 quarters · filed 2014-03-14 | $13.68M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $13.16M 10-Q · filed 2013-05-08 | $13.20M derived: sum of 2 quarters · filed 2014-03-14 | $13.48M derived: sum of 3 quarters · filed 2014-03-14 | $13.72M derived: sum of 4 quarters · filed 2014-03-14 | $234.45M 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $328.00K derived: sum of 2 quarters · filed 2014-03-14 | $564.00K derived: sum of 3 quarters · filed 2014-03-14 | $42.48M 10-K · filed 2014-03-14 | $221.29M 10-K · filed 2012-03-13 | |||
| 2011-09-30 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $519.00K derived: sum of 2 quarters · filed 2012-11-08 | $42.44M 10-Q · filed 2012-11-08 | $43.49M derived: sum of 4 quarters · filed 2013-03-15 | $221.25M 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | $236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $42.15M 10-Q · filed 2012-08-09 | $43.21M derived: sum of 3 quarters · filed 2013-03-15 | $43.23M derived: sum of 4 quarters · filed 2013-03-15 | $220.96M 10-Q · filed 2011-08-09 | |||
| 2011-03-31 | $41.92M 10-Q · filed 2012-05-10 | $42.98M derived: sum of 2 quarters · filed 2013-03-15 | $42.99M derived: sum of 3 quarters · filed 2013-03-15 | |||||
| 2010-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $1.07M derived: sum of 2 quarters · filed 2013-03-15 | $23.00M 10-K · filed 2013-03-15 | |||||
| 2010-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $21.94M 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | $21.92M 10-Q · filed 2011-08-09 | |||||||
| 2009-12-31 | $23.52M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |